Gessica Kayane, known as Gkay to her 20 million followers, touched down at an unidentified airport on April 10 and had to ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best ADR stocks. American Depositary Receipts (ADR) are US-listed securities that represent shares ...

Currently Managing Director of Motley Fool Money, Brendan has worked full-time for The Motley Fool since 2011. He has written hundreds of articles for The Motley Fool and provided analysis on TV ...

BP bosses received a much-needed boost as an advisory firm backed the re-election of the entire board and management. Institutional Shareholder Services said shareholders should vote to back the ...

Robin has worked as a credit cards, editor and spokesperson for over a decade. Prior to Forbes Advisor, she also covered credit cards and related content for other national web publications ...

GSK plc GSK announced that the FDA has approved ... A commercial launch for the drug is planned in second-half 2025 under the brand name Blujepa. This approval for Blujepa marks the introduction ...

The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to ... a UTI that comes back after treatment, drugmaker GSK said. Recurrent UTIs have become a bigger problem ...

TUESDAY, March 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract infections (uUTIs) in adult ...

Billal Rahman is an immigration reporter based in London, U.K. He specializes in immigration policy and border security. He has uncovered allegations of misconduct among border agents under ...

She has over 10 years of experience in digital publishing and three years of experience covering financial topics like insurance, mortgages, and credit cards. Before starting at Investopedia ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other most undervalued biotech stocks to invest in. On February 21, Jared Holz, Mizuho Securities ...